Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliance Certificate Of Novartis India Limited ('The Company') Under Regulation 7(3) Read With Regulation 7(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('SEBI Listing Regulation')

 We hereby confirm that during the half year ended on September 30, 2020, all the activities in relation to the facility of transferring the Equity Shares of the Company, both in physical and electronic form, were duly maintained by the Registrar and Share Transfer Agent of the Company viz. Link Intime India Private Limited, registered in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058 and having its registered Office at C - 101, 247 Park, L. B. S. Marg, Vikroli West, Mumbai - 400083. This is for your information and record.
27-10-2020
Bigul

Novartis India Ltd - 500672 - Shareholding for the Period Ended September 30, 2020

 Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
21-10-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer
21-10-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/ Madam, In reference to the above captioned subject, the certificate dated October 7, 2020, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms of the provisions of the said Regulations, for the quarter ended September 30, 2020, is enclosed herewith for your records as Annexure 1. This is for your information and record.
07-10-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on October 1, 2020. This is for your information and record.
01-10-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited

 NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2020 ,inter alia, to consider and approve the Unaudited Financial results of the Company for the quarter and half year ending on September 30, 2020. In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Thursday, October 1, 2020 to Saturday, November 7, 2020 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information.
30-09-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

 Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 5, 2020, to inter alia consider the Unaudited Financial results of the Company for the quarter and half year ending on September 30, 2020. In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Thursday, October 1, 2020 to Saturday, November 7, 2020 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information.
30-09-2020
Bigul

Vaccines not enough to fight Covid: Novartis CEO

 Vaccines not enough to fight Covid: Novartis CEOEven once such a vaccine is on the market, Novartis AG Chief Executive Officer Vas Narasimhan said, it probably won't protect everyone -- as is the case with seasonal flu.
30-09-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder: Stop Transfer date - September 16, 2020 Folio No. - 02099594 Name - Harsha Jamnadas Kamdar Certificate No. 12863 Distinctive No. 4145374 - 4145553 No. of shares - 180 Reason - Lost by the holder The Registrar and Share Transfer Agent of the Company i.e. Link lntime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same today i.e. on September 17, 2020. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof.
17-09-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder: Stop transfer date - August 31, 2020 Folio no. 03089002 Name- Ranchhodlal M. Chokshi Certificate no . 20663 Distinctive number - 15780648 - 15780827 No. of shares - 180 Reason - Lost by holder The Registrar and Share Transfer Agent of the Company i.e. Link lntime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same today i.e. on September 1, 2020. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof. Thanking you
01-09-2020
Next Page
Close

Let's Open Free Demat Account